Chartwell Investment Partners, LLC Mirum Pharmaceuticals, Inc. Put Options Transaction History
Chartwell Investment Partners, LLC
- $2.91 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
210Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$346 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$241 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$171 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$147 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$137 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.94B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...